关注
Pranav Tandon
Pranav Tandon
Temerty Faculty of Medicine, University of Toronto
在 mail.utoronto.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis
AD Bai, CKL Lo, AS Komorowski, M Suresh, K Guo, A Garg, P Tandon, ...
Clinical Microbiology and Infection 28 (8), 1076-1084, 2022
1582022
Biosecurity and water, sanitation, and hygiene (WASH) interventions in animal agricultural settings for reducing infection burden, antibiotic use, and antibiotic resistance: a …
CEP Jimenez, S Keestra, P Tandon, O Cumming, AJ Pickering, ...
The Lancet Planetary Health 7 (5), e418-e434, 2023
502023
Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review
AD Bai, AS Komorowski, CKL Lo, P Tandon, XX Li, V Mokashi, ...
BMC Medical Research Methodology 21, 1-10, 2021
272021
Making a COVID-19 vaccine that works for everyone: ensuring equity and inclusivity in clinical trials
T Pepperrell, F Rodgers, P Tandon, K Sarsfield, M Pugh-Jones, T Rashid, ...
Global Health Action 14 (1892309), 1-6, 2021
262021
Staphylococcus aureus bacteremia mortality across country income groups: A secondary analysis of a systematic review
AD Bai, CKL Lo, AS Komorowski, M Suresh, K Guo, A Garg, P Tandon, ...
International Journal of Infectious Diseases 122, 405-411, 2022
192022
One Health WASH: an AMR-smart integrative approach to preventing and controlling infection in farming communities
CEP Jimenez, SM Keestra, P Tandon, AJ Pickering, A Moodley, ...
BMJ global health 8 (3), e011263, 2023
132023
How Generalizable Are Randomized Controlled Trials (RCTs) in Staphylococcus aureus Bacteremia? A Description of the Mortality Gap Between RCTs and …
AD Bai, CKL Lo, AS Komorowski, M Suresh, K Guo, A Garg, P Tandon, ...
Clinical Infectious Diseases 75 (8), 1449-1452, 2022
132022
What Is the Optimal Follow-up Length for Mortality in Staphylococcus aureus Bacteremia? Observations From a Systematic Review of Attributable Mortality
AD Bai, CKL Lo, AS Komorowski, M Suresh, K Guo, A Garg, P Tandon, ...
Open Forum Infectious Diseases 9 (5), ofac096, 2022
112022
Methodological and reporting quality of noninferiority randomized controlled trials comparing antibiotic therapies: a systematic review
AD Bai, AS Komorowski, CKL Lo, P Tandon, XX Li, V Mokashi, ...
Clinical Infectious Diseases 73 (7), e1696-e1705, 2021
102021
WASH and biosecurity interventions for reducing burdens of infection, antibiotic use and antimicrobial resistance in animal agricultural settings: a One Health mixed methods …
C Pinto J, S Keestra, P Tandon, CIR Chandler
London School of Hygiene & Tropical Medicine, 2020
82020
Novel antibiotics may be noninferior but are they becoming less effective?: a systematic review
AD Bai, AS Komorowski, CKL Lo, P Tandon, XX Li, V Mokashi, ...
Antimicrobial Agents and Chemotherapy 64 (11), 10.1128/aac. 01597-20, 2020
82020
Confidence interval of risk difference by different statistical methods and its impact on the study conclusion in antibiotic non-inferiority trials
AD Bai, AS Komorowski, CKL Lo, P Tandon, XX Li, V Mokashi, ...
Trials 22, 1-10, 2021
42021
Antimicrobial Resistance: a bottleneck in the achievement of the united nations’ sustainable development goals
P Tandon, K Bouzanis
Global Health: Annual Review 1 (6), 2021
32021
Ethical, public health, and economic dimensions of the inequitable global distribution of COVID-19 vaccines
P Tandon
University of Toronto Medical Journal, 18-22, 2021
32021
Association between the simplified Pulmonary Embolism Severity Index (sPESI) score and hospitalization in emergency department patients diagnosed with pulmonary embolism
P Tandon, C Thompson, K Li, SL McLeod, K de Wit, K Grewal
Thrombosis Research, 2024
2024
2277. Variability in Changes in Physician Outpatient Antibiotic Prescribing from 2019 to 2021 during the COVID-19 Pandemic in Ontario, Canada
P Tandon, K Brown, N Daneman, BJ Langford, V Leung, L Friedman, ...
Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 1899, 2023
2023
Variability in changes in physician outpatient antibiotic prescribing from 2019 to 2021 during the COVID-19 pandemic in Ontario, Canada
P Tandon, KA Brown, N Daneman, BJ Langford, V Leung, L Friedman, ...
Antimicrobial Stewardship & Healthcare Epidemiology 3 (1), e171, 2023
2023
Human Challenge Studies for COVID-19 Vaccines – Reckless or Resourceful?
P Tandon
University of Toronto Medical Journal 98 (2), 13-17, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–18